SEC Form 4 · accession 0001144204-15-001664
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda L Chang
Officer — SVP, CFO & Secretary
Period of report
Jan 7, 2015
Accepted (ET)
Jan 9, 2015 · 7:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Jan 7, 2015 | M | 29,600 | $1.13 | A | 59,600 | D | |
| Common Stock, $0.0001 par value per shareF2 | Jan 7, 2015 | S | 29,600 | $2.10 | D | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF3 | $1.13 | Jan 7, 2015 | M | 29,600 | D | — | Dec 3, 2022 | Common Stock | 29,600 | 45,400 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.
- F2These shares were sold in multiple transactions all at the same price of $2.10 per share.
- F3These options were part of a grant of 75,000 options on 12/03/2012, which vest 25% on each of the first, second, third and fourth anniversaries of the grant date.